IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Life Science Advisors, LLC

Portfolio Profile

CIK: 0001917529 | CAMBRIDGE, MA

Investment Profile

Style

GARP

Turnover

Medium

Orientation

Concentrated trader
$881.3M
AUM
7
Positions
100%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Kymera Therapeutics, Inc.(KYMR)2,847,541$326.5M37.05%
2Dyne Therapeutics, Inc.(DYN)6,800,099$151.0M17.14%
3Sionna Therapeutics, Inc.(SION)2,995,602$131.8M14.95%
4Kailera Therapeutics, Inc.(KLRA)5,171,282$113.9M12.93%
5Disc Medicine, Inc.(IRON)1,513,875$110.7M12.56%

Sector Allocation

Latest filing, equity positions only

Healthcare87.07% · $767.4M
Unclassified12.93% · $113.9M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare100%87.07%-12.93%
Unclassified0%12.93%+12.93%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$803.6M | 15 pos.
$645.6M | 15 pos.
$839.8M | 16 pos.
$1.1B | 16 pos.
$949.6M | 15 pos.
$1.1B | 14 pos.
6
Q32 Bio, Inc.(QTTB)
2,717,106
$34.6M
3.93%
7Korro Bio, Inc.(KRRO)962,884$12.7M1.44%
Cap SizePrev %Curr %Change
Mid Cap81.47%66.75%-14.72%
Small Cap15.2%14.95%-0.25%
Unclassified0%12.93%+12.93%
Micro Cap3.33%5.37%+2.04%
$819.7M | 13 pos.
$521.8M | 13 pos.
$662.4M | 11 pos.
$752.6M | 9 pos.
$790.0M | 6 pos.
$881.3M | 7 pos.
Q2
23
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
0
Closed
1
Increased
3
Decreased
2
Unchanged